Table 3.
Comparison of the ASRQ subscales between AAA patients of the MetAAA trial and monitoring study as a measure of health-related quality of life
| ASRQ subscales | MetAAA trial cohort | AAA monitoring cohort | P | ||
|---|---|---|---|---|---|
| Appearance of negative symptoms | n/N of items | % | n/N of items | % | |
| General malaise | 230/1275 | 18.04 | 92/351 | 26.21 | 0.001 |
| Weight | 54/424 | 12.74 | 19/116 | 16.38 | 0.309 |
| Emotional | 219/1265 | 17.31 | 92/344 | 26.74 | <0.001 |
| Lower limb | 261/1272 | 20.52 | 99/351 | 28.21 | 0.002 |
| Cognitive | 151/850 | 17.76 | 70/234 | 29.91 | <0.001 |
| Gastrointestinal | 152/1127 | 13.49 | 72/312 | 23.08 | <0.001 |
| Total appearance of negative symptoms | 1067/6213 | 17.17 | 444/1708 | 26.00 | <0.001 |
| Other negative symptoms (non-assignable) | 7/142 | 4.90 | 4/39 | 10.26 | 0.217 |
| Limitations due to symptoms | n (of questionnaires) | Mean [%] (SD) | n (of questionnaires) | Mean [%] (SD) | |
| General malaise | 95 | 49.85 (24.07) | 33 | 60.31 (21.64) | 0.021 |
| Weight | 47 | 33.70 (31.90) | 14 | 35.36 (34.77) | 0.873 |
| Emotional | 83 | 45.14 (21.00) | 30 | 54.73 (21.06) | 0.060 |
| Lower limb | 89 | 56.23 (26.84) | 32 | 53.77 (27.66) | 0.969 |
| Cognitive | 75 | 48.80 (24.52) | 30 | 51.15 (26.00) | 0.838 |
| Gastrointestinal | 81 | 56.22 (25.28) | 27 | 57.59 (22.63) | 0.686 |
| Total limitations due to symptoms | 127 | 48.84 (19.21) | 38 | 52.82 (19.64) | 0.182 |
Scores represent the percentage of total possible score achieved. The following statistical analyses were applied: χ²-test and Mann–Whitney U test. Boldface entries indicate statistical significance.
AAA, abdominal aortic aneurysm; ASRQ, Aneurysm Symptom Rating Questionnaire; n, number of applicable items; N, total number of items; SD, standard deviation.